Child development / ADHD · VR + tablet

ForcusGenius™ADHD Solution

A VR-based system combining immersive scenarios, eye-tracking tasks and AI-assisted analysis to support ADHD assessment and individualized rehabilitation training. Clinicians select activities and interpret task results within the care plan.

A promotional child training scene from the LumiBrain ADHD manualLumiBrain care scenario

Product Features

Focused Attention Tasks

Sustained-attention practice with controlled distractors.

Adaptive Practice

Clinician-selected tasks with adjustable difficulty.

Measurable Sessions

Responses, reaction times and errors support progress review.

Technology Principles

Immersive Tasks

VR scenarios present structured visual and interactive activities in a controlled task environment.

Eye Tracking and Responses

Supported modules record gaze and task responses. Measurements are interpreted within the assessment protocol.

Individualized Training

Professionals select suitable activities and difficulty, then review session records to adjust the plan.

Explore the technology

Product Experience

Training Tasks and Session Review

Explore task interfaces from supplied product material. These illustrate training content, not a live clinical dashboard.

Sustained Attention

Practice maintaining attention during structured tasks.

Response Control

Practice responding to relevant targets while managing distractors.

Executive Function

Select tasks and difficulty according to the professional assessment and training goals.

From Task Selection to Progress Review

  1. Select the participant and an appropriate activity
  2. Guide the session and observe tolerability
  3. Review task responses and session records
  4. Adjust the next training plan with the clinician

From Clinical Assessment to Continued Care

Where It Fits

Child development and rehabilitation clinics
Pediatric neurology services
Clinician-guided family training
Attention and learning-support programs

A Structured Workflow

1Review the child’s clinical assessment
2Select appropriate tasks and difficulty
3Record practice and tolerability
4Review task performance with family and clinician

Product Resources

Clinical Evidence and Market Scope

Independent scientific context. Product-specific efficacy studies were not identified in the supplied material.

Plan Your Deployment

Use this checklist to scope a demonstration and technical evaluation with our team.

Before the Demonstration

Share your country, care setting, intended users and preferred product modules.

During Technical Evaluation

Confirm the supported headset or tablet, training environment, user supervision and reporting needs.

Before Rollout

Agree on local availability, deployment configuration, data handling, training, support and acceptance criteria.

Integration, hosting location, response times and service terms are confirmed for each project. This page does not promise a specific interface or installation time.

PRODUCT QUESTIONS

Questions About This Solution

What is ForcusGenius™ designed to support?

ForcusGenius™ presents guided VR and tablet practice focused on attention and executive function, with session review and activities adapted to the selected care plan.

Explore digital practice

Does attention training diagnose ADHD?

Attention practice is distinct from a clinical ADHD assessment. Training activity or task performance alone should not be treated as an ADHD diagnosis.

Discuss the intended care pathway

What evidence is listed for ForcusGenius™?

The supplied library provides independent scientific context. Product-specific efficacy studies were not identified in the supplied material, so those publications do not establish efficacy of the marketed ForcusGenius™ product.

Review research context

Can I assume the product is available in every market?

No. Market documentation must be checked for the specific product, intended use and country. Contact YIWEI MEDICAL to confirm the relevant documentation and availability.

Review market records
GLOBAL COLLABORATION

Build the Future of
Brain Health With Us

We welcome conversations with healthcare providers, research institutions, and international distribution partners.